A Quantitative Approach for Making Go/No-Go Decisions in Drug Development

Longitudinal aggregate data model-based meta-analysis with NONMEM: approaches to handling within treatment arm correlation

(2010) Jae Eun Ahn et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

A Revisit of Sample Size Decisions in Confirmatory Trials

(2010) Christy Chuang-Stein et al.   Statistics in Biopharmaceutical Research

Disease progression meta-analysis model in Alzheimer's disease

(2009) Kaori Ito et al.   Alzheimers & Dementia

From Trial and Error to Trial Simulation. Part 1: The Importance of Model-Based Drug Development for Antidepressant Drugs

(2009) G Santen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

From Trial and Error to Trial Simulation. Part 2: An Appraisal of Current Beliefs in the Design and Analysis of Clinical Trials for Antidepressant Drugs

(2009) G Santen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Literature Review October-December 2008

(2009) Kevin Carroll et al.   PHARMACEUTICAL STATISTICS

Concepts and Challenges in Quantitative Pharmacology and Model-Based Drug Development

(2008) Liping Zhang et al.   AAPS Journal

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

(2008) Jean-Philippe Spano et al.   LANCET

Estimation following selection of the largest of two normal means

(2007) Nigel Stallard et al.   JOURNAL OF STATISTICAL PLANNING AND INFERENCE